No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study.
Linda C A DrenthenMandala AjieEvertine J AbbinkLaura RodwellDick H J ThijssenCornelis Cees J TackBastiaan E De GalanPublished in: Diabetologia (2023)
EudraCT number 2019-004222-22 FUNDING: The study was funded by an unrestricted grant from Novo Nordisk, Denmark.